PI3K alpha inhibitor (PIQUR Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePI3K alpha inhibitor (PIQUR Therapeutics)
Drug Alias NamePQR-3xx
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitors
TargetsPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPiqur Therapeutics Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPiqur Therapeutics Ag
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A